entity

Parkinson's Disease pathology

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Parkinson's Disease pathology: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

7Connections

1Hypotheses

2Analyses

0Outgoing

7Incoming

0Experiments

4Debates

No AI portrait yet

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (7)

Source	Relation	Type	Str
Α-SYNUCLEIN PREFORMED FIBRILS	mediates	protein	0.90
protein aggregate formation	contributes_to	process	0.85
Synaptic Dysfunction	contributes_to	phenotype	0.85
Mitochondrial Metabolic Activities	contributes_to	process	0.80
Mitochondrial Metabolism	associated_with	process	0.80
alpha-synuclein	associated_with	protein	0.70
alpha_synuclein	biomarker_for	protein	0.50

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Age-Accelerated miR-155 Upregulation Primes Nigral Microglia	0.610	neuroinflammation	How do regional, age, and sex-dependent

Mentioning Analyses (2)

Scientific analyses that reference this entity

Gut Microbiome Analysis in Parkinson's Disease

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.778

De Novo Binder Design Targeting Alpha-Synuclein Aggregation Interface

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.571

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (4)

Multi-agent debates referencing this entity

Can computational de novo protein binder design produce stable binders that bloc

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

How does the gut microbiome composition differ between PD patients and healthy c

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

Is the gut microbiome a driver of PD pathology via SCFA depletion, or is dysbios

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Can computationally designed binders against alpha-synuclein realistically trans

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Related Research

Hypotheses and analyses mentioning Parkinson's Disease pathology in their description or question text

No additional research found